EN
TR
Community Acquired Meticilline Resistance S. Aureus
Abstract
CA-MRSA community-acquired, or community-associated Staphylococcus aureus has appeared with increasing frequency and is now epidemic within certain community populations. Whereas hospital associated MRSA is almost always found in persons with established risk factors associated with prior medical treatment, these are not present in CA-MRSA. This form causes serious skin and soft tissue infections in otherwise healthy persons who have not been recently hospitalized or undergone invasive medical procedures. CA-MRSA has been identified most frequently among prisoners, athletes, children, men who have sex with men, and military recruits. A major difference between the two types that CA-MRSA possesses a potent toxin called PantonValentine leukocidin, which attacks infection-fighting leukocytes. The most serious form of CA-MRSA infection causes necrotizing fasciitis. Also it causes serious necrotizing pneumonia and increased complications of hematogenous osteomiyelitis. Two clones strains of staph, called USA300 and USA400, are associated with the CA-MRSA. CA-MRSA has stphylococcal casette chrosome SCC mec IV and V as resistance genes unlike HA-MRSA which has I, II and III SCC mec. CA-MRSA is still susceptible to several antibiotic classes outside of the beta-lactam group and macrolides. Bacteria can develope resistance to other antibiotics. Therefore clinicians must be careful at use of them
Keywords
References
- Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998;279:593–598.
- Frank AL, Marcinak JF, Mangat PD, et al. Increase in community-acquired methicillin-resistant Staphylococcus aureus in children. Clin Infect Dis. 1999; 29: 935–936.
- Vandenesch F, Naimi T, Enright MC, Lina G, Nimma GR, Heffernan H, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg. Infect. Dis. 2003; 9: 978–984.
- Dufour P, Gillet Y, Bes M, Lina G, Vandenesch F, Floret D, et al. Community-acquired methicillin- resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis. 2002;35: 819–824
- Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, et al. Association between Staphylococcus aureus strains carrying gene for Panton- Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002;359:753–759
- Van de Velde, H. E ´tude sur la me ´canisme de la virulence du staphylocoque pyogene. Cellule 1894;10: 402–460.
- Panton PN, Valentine FCO. Staphylococcal toxin. Lancet 1932; 219: 506–508.
- Prevost G, Bouakham T, Piemont Y, Monteil H. Characterisation of a synergohymenotropic toxin produced by Staphylococcus intermedius [published correction appears in FEBS Lett. 1996;381:272]. FEBS Lett. 1995;376:135–149.
Details
Primary Language
Turkish
Subjects
-
Journal Section
-
Authors
Hayati Güneş
Emel Sesli Çetin
Publication Date
June 1, 2012
Submission Date
-
Acceptance Date
-
Published in Issue
Year 1970 Number: 2